I know there are others who are hoping to establish practices for their patients to receive this care as well
I'll link to the written summary in the comments: Inside the GLP-1 Study for Long COVID, with lead scientist Dr Julia Vogel, Long Covid, MD Pod, Ep 61 I had just recently learned about the anti-nflammatory properties of GLP-1
There is an excellent presentation from Cambridge University which outlines this: [First trimester embryonic nutrition
Support Secondary Hormone Pathways (GIP, Amylin, Glucagon) GIP-like activity via insulin sensitizers (e.g., SLM+ ) Amylin via pramlintide (Symlin) or future CagriSema protocols Glucagon via activity, resistance training, or upcoming triple agonists Add agents that simulate or stimulate: 2
As a result, levels of L-carnitine tend to vary among people and eating habits